Apogee Therapeutics APGE
APGE
$135.07 +1.11 (+0.83%)
At close: Sep 2, 2026 · 4:00 PM EDT

Apogee Therapeutics (APGE) Other Accumulated Expenses (2022 - 2024)

Updated

Apogee Therapeutics' Other Accumulated Expenses came in at $1.69 million for Q3 2024, up 144.7% from $692,000 a year earlier and up 68.1% from the prior quarter.

Analysis

Apogee Therapeutics (APGE) Other Accumulated Expenses (2022 - 2024) Analysis & Trends

At the end of FY2023, Apogee Therapeutics' Other Accumulated Expenses was $1.24 million, up 521.5% from FY2022.

  • Going back by year, Other Accumulated Expenses was $200,000 in FY2022.
  • The five-year range for quarterly Other Accumulated Expenses is $200,000 (Q4 2022) to $2.14 million (Q1 2024).
  • Business Quant data shows APGE's Other Accumulated Expenses at $1.01 million (Q2 2024), $2.14 million (Q1 2024) and $1.24 million (Q4 2023) in the three quarters before Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Apogee Therapeutics 10.18 Bn 7.68 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 1.69 Mn
Jun 30, 2024 1.01 Mn
Mar 31, 2024 2.14 Mn
Dec 31, 2023 1.24 Mn
Sep 30, 2023 692,000.00
Jun 30, 2023 1.83 Mn
Dec 31, 2022 200,000.00
API Access

Apogee Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=APGE&period=max&api_key=YOUR_API_KEY